Unknown

Dataset Information

0

Significant association of PRMT6 hypomethylation with colorectal cancer.


ABSTRACT: BACKGROUND:Protein arginine N-methyltransferase 6 (PRMT6) was deemed to be indispensable in the variety of biological processes. Upregulated PRMT6 was found in various human diseases including cancer. Herein, we investigated the performance of PRMT6 methylation in the diagnosis for CRC. METHODS:A quantitative methylation-specific polymerase chain reaction (qMSP) method was used to measure PRMT6 promoter methylation. The percentage of methylated reference (PMR) was applied to represent gene methylation level. RESULTS:Our data indicated that PRMT6 promoter methylation levels were significantly lower in CRC tissues than those in paired nontumor tissues (median PMR: 36.93% vs 63.12%, P = 1E-6) and normal intestinal tissues (median PMR: 36.93% vs 506.55%, P = 8E-12). We further examined the potential role of PRMT6 hypomethylation by the receiver operating characteristic (ROC) curve. Our results showed that the area under the curve (AUC) was 0.644 (95% CI = 0.596-0.733) between CRC tissues and paired nontumor tissues, 0.958 (95% CI = 0.919-0.998) between CRC tissues and normal intestinal tissues, and 0.899 (95% CI = 0.825-0.972) between paired nontumor tissues and normal intestinal tissues. CONCLUSION:Our study firstly indicated that the hypomethylation of PRMT6 promoter could be a novel diagnostic biomarker for CRC.

SUBMITTER: Pan R 

PROVIDER: S-EPMC6816985 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Significant association of PRMT6 hypomethylation with colorectal cancer.

Pan Ranran R   Yu Hang H   Dai Jie J   Zhou Cong C   Ying Xiuru X   Zhong Jie J   Zhao Jun J   Zhang Yihan Y   Wu Boyi B   Mao Yiyi Y   Wu Dongping D   Ying Jieer J   Duan Shiwei S  

Journal of clinical laboratory analysis 20180621 9


<h4>Background</h4>Protein arginine N-methyltransferase 6 (PRMT6) was deemed to be indispensable in the variety of biological processes. Upregulated PRMT6 was found in various human diseases including cancer. Herein, we investigated the performance of PRMT6 methylation in the diagnosis for CRC.<h4>Methods</h4>A quantitative methylation-specific polymerase chain reaction (qMSP) method was used to measure PRMT6 promoter methylation. The percentage of methylated reference (PMR) was applied to repre  ...[more]

Similar Datasets

| S-EPMC6607394 | biostudies-literature
| S-EPMC5753604 | biostudies-literature
| S-EPMC7498186 | biostudies-literature
| S-EPMC2515372 | biostudies-literature
| S-EPMC8784229 | biostudies-literature
| S-EPMC5665761 | biostudies-literature
| S-EPMC4513664 | biostudies-literature
| S-EPMC7582763 | biostudies-literature
| S-EPMC3493855 | biostudies-literature
| S-EPMC8931394 | biostudies-literature